Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Total Non-Current Liabilities (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Total Non-Current Liabilities came in at $2.2 billion in Q2 2026, down 2.57% on a YoY basis from $2.2 billion in Q2 2025, and up 1.53% quarter-over-quarter from $2.1 billion in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Total Non-Current Liabilities for 5 consecutive years, with $2.2 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Non-Current Liabilities fell 2.57% year-over-year to $2.2 billion; the trailing twelve-month figure through Jun 2026 stood at $2.2 billion (down 2.57% YoY), and the FY2025 full-year result was $2.1 billion, down 3.14% from the prior year.
  • Total Non-Current Liabilities advanced to $2.2 billion in Q2 2026 per FTRE's latest filing, from $2.1 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.6 billion in Q1 2024 and bottomed at $923.6 million in Q4 2022.
  • Historically, Total Non-Current Liabilities has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2024.
  • The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities surged 180.03% in 2023, then retreated 19.21% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $923.6 million in 2022, then soared by 180.03% to $2.6 billion in 2023, then declined by 15.65% to $2.2 billion in 2024, then declined by 3.14% to $2.1 billion in 2025, then increased by 1.86% to $2.2 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $2.2 billion, $2.1 billion, and $2.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 22.94 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 1.56 Bn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 4.24 Bn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 6.94 Bn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 2.15 Bn
6 Evotec SE 661.34 Mn 235.46 Mn - 30.49 Mn
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn 553.39 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn 22.91 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -
10 VivoSim Labs 1.47 Mn 1.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.15 Bn
Mar 31, 2026 2.12 Bn
Dec 31, 2025 2.11 Bn
Sep 30, 2025 2.12 Bn
Jun 30, 2025 2.21 Bn
Mar 31, 2025 2.23 Bn
Dec 31, 2024 2.18 Bn
Sep 30, 2024 2.11 Bn
Jun 30, 2024 2.07 Bn
Mar 31, 2024 2.62 Bn
Dec 31, 2023 2.59 Bn
Sep 30, 2023 2.59 Bn
Jun 30, 2023 2.57 Bn
Dec 31, 2022 923.60 Mn